Article
Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population.
Pharmacogenetics - 1 Feb 2001
Loriot M A, Rebuissou S, Oscarson M, Cenée S, Miyamoto M, Ariyoshi N, Kamataki T, Hémon D, Beaune P, Stücker I
Abstract excerpt
Cytochrome P450 2A6 (CYP2A6) is involved in the C-oxidation of nicotine and in the metabolic activation of tobacco nitrosamines. Recent data have suggested that CYP2A6 genetic polymorphisms might play a role in tobacco dependence and consumption as well as in lung cancer risk. However, the previously published studies were based on a genotyping method that overestimated the frequencies of deficient alleles,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.